Phase I clinical study of N-[(4-chlorophenyl)amino]carbonyl-2,3-dihydro-1H-indene-5-sulfonamide (LY186641).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples